Abiomed, Inc.
ABMD · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $137 | $226 | $203 | $259 |
| Dep. & Amort. | $28 | $24 | $20 | $14 |
| Deferred Tax | $2 | $29 | $33 | -$8 |
| Stock-Based Comp. | $53 | $47 | $40 | $0 |
| Change in WC | -$30 | -$17 | $8 | -$39 |
| Other Non-Cash | $96 | -$34 | $11 | -$29 |
| Operating Cash Flow | $285 | $275 | $315 | $252 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$36 | -$53 | -$44 | -$44 |
| Net Acquisitions | -$83 | -$52 | $0 | $0 |
| Inv. Purchases | -$806 | -$582 | -$632 | -$404 |
| Inv. Sales/Matur. | $544 | $465 | $551 | $332 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$381 | -$223 | -$125 | -$116 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7 | $5 | $5 | $3 |
| Stock Repurch. | $0 | -$11 | -$85 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$8 | -$118 | -$56 |
| Financing Cash Flow | -$2 | -$8 | -$118 | -$56 |
| Forex Effect | -$2 | -$3 | -$0 | -$2 |
| Net Chg. in Cash | -$100 | $40 | $71 | $78 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $233 | $192 | $121 | $43 |
| End Cash | $133 | $233 | $192 | $121 |
| Free Cash Flow | $250 | $221 | $271 | $208 |